# Sex- and Exercise-Dependent Modulation of Hypertrophic Remodeling by the MCT1 rs1049434 Polymorphism

**Authors:** Natalia Fernández-Suárez, María Teresa Viadero, Teresa Amigo, José Antonio Benitez-Muñoz, Rocío Cupeiro, Domingo González-Lamuño

PMC · DOI: 10.3390/genes17020188 · Genes · 2026-02-02

## TL;DR

This study shows that a genetic variant in MCT1 affects heart muscle thickening differently in men and women, and exercise can reduce disease severity in men.

## Contribution

The study reveals a genotype–sex–environment interaction in hypertrophic cardiomyopathy, highlighting sex-specific and exercise-dependent effects of the MCT1 rs1049434 polymorphism.

## Key findings

- Female carriers of the T-allele (TT/TA) had significantly greater septal thickness compared to AA homozygotes.
- Male patients engaging in vigorous exercise showed a milder structural phenotype and favorable mechanical markers.
- Phenotypic distribution was predominantly asymmetric septal hypertrophy in both sexes, without genotype-dependent differences.

## Abstract

Background: The monocarboxylate transporter 1 (MCT1) plays a central role in myocardial lactate handling and metabolic adaptation. The functional rs1049434 polymorphism (T1470A; Asp490Glu) affects MCT1-mediated lactate transport and substrate utilization, but its clinical relevance in sarcomere-related hypertrophic cardiomyopathy (HCM) remains poorly defined. Methods: We studied 56 carriers of pathogenic or likely pathogenic sarcomeric variants examined in a familial HCM program. All participants underwent standardized clinical phenotyping, including electrocardiography, transthoracic echocardiography, and cardiac magnetic resonance imaging. Genotyping of MCT1 rs1049434 was performed on genomic DNA. Analyses focused on sex-stratified genotype distribution, phenotypic expression among the 26 individuals who fulfilled diagnostic criteria for HCM, and the influence of habitual vigorous exercise. Septal wall thickness was the primary structural endpoint. Results: Among the 26 patients with established HCM (10 women, 16 men), a marked sex-specific effect emerged. Female carriers of the T-allele (TT/TA) exhibited significantly greater interventricular septal thickness compared with AA homozygotes (23.2 vs. 14.2 mm; p = 0.037). In men, septal thickness did not differ by genotype. However, male patients engaged in vigorous physical activity showed a consistently milder structural phenotype, including lower septal thickness (18.3 vs. 19.9 mm; p = 0.585) and directionally favorable markers of mechanical severity. Phenotypic distribution was predominantly asymmetric septal hypertrophy in both sexes, without genotype-dependent differences. Conclusions: The phenotypic impact of MCT1 rs1049434 in sarcomere-positive HCM is context-dependent. In women, impaired monocarboxylate handling is associated with greater hypertrophic remodeling, whereas in men, exercise-related metabolic conditioning appears to attenuate disease severity. These findings support a genotype–sex–environment interaction relevant to precision medicine approaches in HCM.

## Linked entities

- **Genes:** CMA1 (chymase 1) [NCBI Gene 1215]
- **Diseases:** hypertrophic cardiomyopathy (MONDO:0005045)

## Full-text entities

- **Genes:** MYBPC3 (myosin binding protein C3) [NCBI Gene 4607] {aka CMD1MM, CMH4, FHC, LVNC10, MYBP-C, cMyBP-C}, TNNI3 (troponin I3, cardiac type) [NCBI Gene 7137] {aka CMD1FF, CMD2A, CMH7, RCM1, TNNC1, cTnI}, SLC16A3 (solute carrier family 16 member 3) [NCBI Gene 9123] {aka MCT 3, MCT 4, MCT-3, MCT-4, MCT3, MCT4}, TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}, MYL3 (myosin light chain 3) [NCBI Gene 4634] {aka CMH8, MLC-lV/sb, MLC1SB, MLC1V, VLC1, VLCl}, SLC16A1 (solute carrier family 16 member 1) [NCBI Gene 6566] {aka HHF7, MCT, MCT1, MCT1D}, MYH7 (myosin heavy chain 7) [NCBI Gene 4625] {aka CMD1S, CMH1, CMYO7A, CMYO7B, CMYP7A, CMYP7B}, ACTC1 (actin alpha cardiac muscle 1) [NCBI Gene 70] {aka ACTC, ASD5, CMD1R, CMH11, LVNC4}
- **Diseases:** left ventricular outflow tract obstruction (MESH:D000092242), myocardial fibrosis (MESH:D005355), injury to (MESH:D014947), Arrhythmic Burden (OMIM:212500), inherited heart disease (MESH:D030342), cardiomyopathies (MESH:D009202), arrhythmias (MESH:D001145), diastolic dysfunction (MESH:D018487), hypertrophy (MESH:D006984), left ventricular hypertrophy (MESH:D017379), left atrial enlargement (MESH:D059446), sarcomeric dysfunction (MESH:D006331), hypertrophic remodeling (MESH:D020257), HCM (MESH:D002312), heart failure (MESH:D006333)
- **Chemicals:** lactate (MESH:D019344), pyruvate (MESH:D019289), fatty acid (MESH:D005227), acid-base (-), glucose (MESH:D005947)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Mutations:** Ala797Thr, R820W, rs1049434, I mutations in 748

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940516/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940516/full.md

---
Source: https://tomesphere.com/paper/PMC12940516